These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22160363)

  • 1. Fibroblast growth factor 2-functionalized collagen matrices for skeletal muscle tissue engineering.
    Yun YR; Lee S; Jeon E; Kang W; Kim KH; Kim HW; Jang JH
    Biotechnol Lett; 2012 Apr; 34(4):771-8. PubMed ID: 22160363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering and application of collagen-binding fibroblast growth factor 2 for sustained release.
    Jeon E; Yun YR; Kim HW; Jang JH
    J Biomed Mater Res A; 2014 Jan; 102(1):1-7. PubMed ID: 23468239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells.
    Sato M; Ito A; Kawabe Y; Nagamori E; Kamihira M
    J Biosci Bioeng; 2011 Sep; 112(3):273-8. PubMed ID: 21646045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury.
    Tanaka T; Saika S; Ohnishi Y; Ooshima A; McAvoy JW; Liu CY; Azhar M; Doetschman T; Kao WW
    Mol Vis; 2004 Jul; 10():462-7. PubMed ID: 15273655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration.
    Villena J; Brandan E
    J Cell Physiol; 2004 Feb; 198(2):169-78. PubMed ID: 14603519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual activities of 22-24 kDA basic fibroblast growth factor: inhibition of migration and stimulation of proliferation.
    Piotrowicz RS; Maher PA; Levin EG
    J Cell Physiol; 1999 Feb; 178(2):144-53. PubMed ID: 10048578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenous matrices as release carriers of exogenous growth factors.
    Kanematsu A; Yamamoto S; Ozeki M; Noguchi T; Kanatani I; Ogawa O; Tabata Y
    Biomaterials; 2004 Aug; 25(18):4513-20. PubMed ID: 15046942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-Based Coacervate of FGF2 Improves Dermal Regeneration by Asserting a Synergistic Role with Cell Proliferation and Endogenous Facilitated VEGF for Cutaneous Wound Healing.
    Wu J; Ye J; Zhu J; Xiao Z; He C; Shi H; Wang Y; Lin C; Zhang H; Zhao Y; Fu X; Chen H; Li X; Li L; Zheng J; Xiao J
    Biomacromolecules; 2016 Jun; 17(6):2168-77. PubMed ID: 27196997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor supplemented matrigel improves ectopic skeletal muscle formation--a cell therapy approach.
    Barbero A; Benelli R; Minghelli S; Tosetti F; Dorcaratto A; Ponzetto C; Wernig A; Cullen MJ; Albini A; Noonan DM
    J Cell Physiol; 2001 Feb; 186(2):183-92. PubMed ID: 11169455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth.
    Nozaki M; Li Y; Zhu J; Ambrosio F; Uehara K; Fu FH; Huard J
    Am J Sports Med; 2008 Dec; 36(12):2354-62. PubMed ID: 18725651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2-overexpressing myoblasts encapsulated in alginate spheres increase proliferation, reduce apoptosis, induce adipogenesis, and enhance regeneration following skeletal muscle injury in rats.
    Stratos I; Madry H; Rotter R; Weimer A; Graff J; Cucchiarini M; Mittlmeier T; Vollmar B
    Tissue Eng Part A; 2011 Nov; 17(21-22):2867-77. PubMed ID: 21815803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of relaxin treatment on skeletal muscle injuries.
    Negishi S; Li Y; Usas A; Fu FH; Huard J
    Am J Sports Med; 2005 Dec; 33(12):1816-24. PubMed ID: 16157846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin.
    Bhang SH; Sun AY; Yang HS; Rhim T; Kim DI; Kim BS
    Biotechnol Lett; 2011 Apr; 33(4):845-51. PubMed ID: 21140191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation.
    Li G; Peng H; Corsi K; Usas A; Olshanski A; Huard J
    J Bone Miner Res; 2005 Sep; 20(9):1611-23. PubMed ID: 16059633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel method for fabrication of skeletal muscle construct from the C2C12 myoblast cell line using serum-free medium AIM-V.
    Fujita H; Shimizu K; Nagamori E
    Biotechnol Bioeng; 2009 Aug; 103(5):1034-41. PubMed ID: 19350625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2).
    Princz MA; Sheardown H
    J Biomater Sci Polym Ed; 2008; 19(9):1201-18. PubMed ID: 18727861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice.
    McCroskery S; Thomas M; Platt L; Hennebry A; Nishimura T; McLeay L; Sharma M; Kambadur R
    J Cell Sci; 2005 Aug; 118(Pt 15):3531-41. PubMed ID: 16079293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of bFGF-chitosan matrices and their interactions with human dermal fibroblast cells.
    Lefler A; Ghanem A
    J Biomater Sci Polym Ed; 2009; 20(10):1335-51. PubMed ID: 19622275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glypican-1 on turkey skeletal muscle cell proliferation, differentiation and fibroblast growth factor 2 responsiveness.
    Velleman SG; Liu C; Coy CS; McFarland DC
    Dev Growth Differ; 2006 May; 48(4):271-6. PubMed ID: 16681652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.